Researchers analyzed data from a group of 292 children under the age of 7 who have Type 1 Diabetes. The study compared standard care to automated insulin delivery (AID) systems over a period of 8 to 16 weeks.
The results showed that children using AID systems spent more time in their target blood sugar range, with an average increase of 9.29 percent. These children also saw a decrease in their HbA1c levels by 0.39 percent. Additionally, the use of these systems led to lower mean blood glucose and less time spent with high blood sugar.
Importantly, the study found no significant difference between standard care and automated systems regarding insulin doses or the risk of serious complications like severe hypoglycemia or diabetic ketoacidosis (DKA). Because these are preliminary findings from a short-term period, more long-term studies are needed to confirm these results. Talk with your doctor to see if this technology is right for your child.
Common questions
How does automated insulin delivery help children with Type 1 Diabetes?
Automated insulin delivery (AID) systems were found to improve the time children spent in their target blood sugar range by an average of 9.29 percent. The study also showed a decrease in HbA1c levels and lower mean blood glucose for children under age 7 using these systems.
Is it safer to use automated insulin delivery than standard care?
The study found no significant difference between automated systems and standard care regarding the risk of severe hypoglycemia or diabetic ketoacidosis (DKA). Both groups showed similar safety profiles in these specific areas during the 8 to 16 week follow-up period.
What are the limitations of this finding?
These results are considered preliminary and were based on a short-term follow-up of 8 to 16 weeks. More long-term studies are needed to fully understand how these systems perform over a longer period for children with Type 1 Diabetes.
